-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on Boston Scientific, Lowers Price Target to $70

Benzinga·07/30/2026 17:27:39
Listen to the news
RBC Capital analyst Kendall Au maintains Boston Scientific (NYSE:BSX) with a Outperform and lowers the price target from $85 to $70.